Fadi Ismail Abu-Shahin, MD
Medical Oncology Physician · Houston, TX
Fadi Ismail Abu-Shahin, MD is a medical oncology physician with a practice address in Houston, Texas, and NPI 1215123971, issued on Sep 17, 2007. Check the license (Texas R7364, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Fadi Ismail Abu-Shahin
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- R7364 TX
Self-reported in NPPES; status is on the state search - Practice location
- 18220 State Highway 249 Ste 100, Houston, TX 77070
- Phone
- (276) 546-2928
- Enumerated
- Sep 17, 2007
- Record last updated
- Dec 2, 2025
- Fax
- (281) 737-0435
- Medicare enrollment
- Enrolled (PECOS I20181012001643); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Also registered at 18220 State Highway 249 Ste 100
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Lolita Ashwood, FNPFamily Nurse Practitioner1992150304
- Guadalupe Rojas, A.R.N.P.Family Nurse Practitioner1770521908
Verify Fadi Ismail Abu-Shahin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license R7364Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
83% more Medicare Part D claims than the average medical oncology physician in 2024
1,288 Medicare Part D claims for 234 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 17% of claims. 142 claims were for opioids.
Most prescribed
- Anastrozole189 claims
- Hydrocodone-Acetaminophen75 claims
- Tamoxifen Citrate74 claims
- Gabapentin71 claims
- Eliquis65 claims
- Ondansetron Odt44 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $238.87
9 payments; by number, the most common kind was food and beverage; the largest payer was Janssen Biotech, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Houston Methodist Specialty PhysiciansHouston, TX
- Tmh Physician Associates PLLCHouston, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Fadi Ismail Abu-Shahin among 547 medical oncology physician records in Texas
Fadi Ismail Abu-Shahin, MD is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 55% of them.
- NPI issued2007 · 55% of these records are older, 34% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated2004 · median 2000 among the 414 with a school on file
- Record last updated2025 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in Houston → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Haris Baig, D.O.Houston, TX 770701699919456
- Anna Belcheva, M. D.Houston, TX 770701518928514
- Henna Malik, M.D.Houston, TX 770701003099813
- Gary Erwin, M.D.Houston, TX 770691528257383
- Robert Furse, M.D.Houston, TX 770741356383590
- Natasha Hirani, DO, MPHHouston, TX 770581659715357
- Amir Salam, M.D.Houston, TX 770581346569316
- Robert Weaver, M.D.Houston, TX 770551720395064
Common questions
What is Fadi Ismail Abu-Shahin, MD's NPI number?
Fadi Ismail Abu-Shahin, MD's National Provider Identifier (NPI) is 1215123971, issued on Sep 17, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Fadi Ismail Abu-Shahin, MD located?
The NPPES record lists a practice address at 18220 State Highway 249 Ste 100, Houston, TX, 77070. Phone: (276) 546-2928. Providers update this record themselves, so call before visiting.
How can I verify Fadi Ismail Abu-Shahin, MD's license?
NPPES lists Texas license number R7364, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Fadi Ismail Abu-Shahin, MD prescribe under Medicare Part D?
In 2024, Fadi Ismail Abu-Shahin, MD had 1,288 Medicare Part D claims for 234 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.